The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Neuroscience Antibodies & Assays Market Expected To Change Between 2026 And 2030?
The neuroscience antibodies & assays market has experienced rapid expansion in recent years. Its size is projected to grow from $5.03 billion in 2025 to $5.76 billion in 2026, with a compound annual growth rate (CAGR) of 14.5%. This historical growth can be attributed to factors such as the rising prevalence of neurological disorders, increased neuroscience research funding, the wider adoption of immunoassays in diagnostics, the availability of advanced laboratory instruments, and the expansion of academic neuroscience programs.
The market for neuroscience antibodies and assays is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of **$9.83 billion by 2030**, demonstrating a compound annual growth rate (CAGR) of **14.3%**. This expansion during the projection period stems from escalating investments in research concerning neurodegenerative diseases, a heightened need for customized neurology diagnostics, the broadening of drug discovery initiatives, the increasing use of automated assay platforms, and a greater emphasis on detecting diseases early. Key trends anticipated over the forecast period encompass the wider embrace of high-specificity antibody reagents, an increase in the utilization of multiplex assay platforms, the growing incorporation of automation within neuro research laboratories, the broadening of neurological studies reliant on biomarkers, and an intensified commitment to reproducibility and sensitivity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp
What Underlying Factors Are Accelerating The Growth Of The Neuroscience Antibodies & Assays Market?
The increasing prevalence of neurological conditions is expected to drive the expansion of the neuroscience antibodies and assays market in the future. Neurological illnesses are disorders that affect the brain, spinal cord, and nerves, resulting in impaired cognitive, motor, or sensory functions. The growing incidents of neurological illnesses are largely a consequence of population aging, as the increasing proportion of older adults in developed countries leads to a higher occurrence of age-related neurological conditions such as Alzheimer’s disease and Parkinson’s disease. The rising incidents of neurological illnesses bolster the demand for specialized antibodies and assays because researchers and clinicians depend on these diagnostic and research tools to detect, investigate, and monitor disease-specific biomarkers and protein abnormalities associated with neurological conditions. For instance, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, and this figure is anticipated to increase to 13.8 million by 2060. Therefore, the rise in incidents of neurological illnesses is fueling the growth of the neuroscience antibodies and assays market.
How Is The Neuroscience Antibodies & Assays Market Structured Across Different Segments?
The neuroscience antibodies & assays market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations
Which Trends Are Shaping The Future Of The Neuroscience Antibodies & Assays Market?
Companies operating in the neuroscience antibodies and assays market are heavily investing in developing innovative products, such as bispecific in vivo–ready antibodies, designed to simultaneously target multiple neurological pathways for achieving more precise and effective research outcomes. These bispecific in vivo–ready antibodies are specifically engineered to bind two different targets concurrently and are formulated for use in live animal models, thereby assisting researchers in modulating multiple neurological pathways at once for more accurate and physiologically relevant neuroscience studies. For instance, in October 2025, Bio X Cell LLC, a US–based biotechnology company, unveiled an expanded catalog of bispecific and ADC (antibody-drug conjugate) antibodies as part of its refreshed brand identity, explicitly targeting advanced preclinical neuroscience and translational research applications. These particular bispecific antibodies are engineered to bind two distinct antigens simultaneously, enabling researchers to modulate multiple signaling pathways or cell populations in the brain within a single study, unlike traditional monoclonal antibodies which target only one molecule. They are produced with a high purity (= 95%) and ultra-low endotoxin levels (= 0.5 EU/mg), making them highly suitable for sensitive in vivo experiments, organoid models, and organ-on-chip systems. Furthermore, the ADCs combine a functional antibody with a cytotoxic payload to selectively target specific neuronal or glial populations, offering precise modulation and enhanced experimental flexibility.
Which Major Players Dominate The Neuroscience Antibodies & Assays Market?
Major companies operating in the neuroscience antibodies & assays market are Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB
Read the full neuroscience antibodies & assays market report here:
Which Region Is Projected To Dominate The Neuroscience Antibodies & Assays Market During The Forecast Period?
North America was the largest region in the neuroscience antibodies & assays market in 2025. The regions covered in the neuroscience antibodies & assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Neuroscience Antibodies & Assays Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7548&type=smp
Browse Through More Reports Similar to the Global Neuroscience Antibodies & Assays Market 2026, By The Business Research Company
Neurological Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report
Next Generation Antibody Therapeutics Market Report 2026
Antibody Discovery Market Report 2026
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model